226 related articles for article (PubMed ID: 23814483)
1. Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
Ghanbari-Azarnier R; Sato S; Wei Q; Al-Jazrawe M; Alman BA
Neoplasia; 2013 Jul; 15(7):712-9. PubMed ID: 23814483
[TBL] [Abstract][Full Text] [Related]
2. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
3. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
4. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).
Li C; Bapat B; Alman BA
Am J Pathol; 1998 Sep; 153(3):709-14. PubMed ID: 9736021
[TBL] [Abstract][Full Text] [Related]
5. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
6. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.
Wu C; Amini-Nik S; Nadesan P; Stanford WL; Alman BA
Cancer Res; 2010 Oct; 70(19):7690-8. PubMed ID: 20841474
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
8. [Biology and signaling pathways involved in the oncogenesis of desmoid tumors].
Salas S; Chibon F
Bull Cancer; 2020 Mar; 107(3):346-351. PubMed ID: 31955867
[TBL] [Abstract][Full Text] [Related]
9. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
Couture J; Mitri A; Lagace R; Smits R; Berk T; Bouchard HL; Fodde R; Alman B; Bapat B
Clin Genet; 2000 Mar; 57(3):205-12. PubMed ID: 10782927
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.
Carothers AM; Rizvi H; Hasson RM; Heit YI; Davids JS; Bertagnolli MM; Cho NL
Cancer Res; 2012 Jan; 72(1):346-55. PubMed ID: 22094874
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells.
Hyun J; Wang S; Kim J; Kim GJ; Jung Y
Sci Rep; 2015 Sep; 5():14135. PubMed ID: 26370741
[TBL] [Abstract][Full Text] [Related]
12. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).
Hong H; Nadesan P; Poon R; Alman BA
Br J Cancer; 2011 Apr; 104(9):1452-8. PubMed ID: 21468052
[TBL] [Abstract][Full Text] [Related]
13. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
14. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
[TBL] [Abstract][Full Text] [Related]
15. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
16. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
18. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
Yang JL; Wang J; Zhou XY; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling.
Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA
J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242
[TBL] [Abstract][Full Text] [Related]
20. Desmoid tumor: a disease opportune for molecular insights.
Kotiligam D; Lazar AJ; Pollock RE; Lev D
Histol Histopathol; 2008 Jan; 23(1):117-26. PubMed ID: 17952864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
